PMP Practice: Monitor and adjust risk management activities
Question 5 of 5 in Assess and Manage Risks
Pick an answer below — you'll get the explanation instantly, no signup.
Show answer & explanation
Correct answer: Maintain the predictive approach with comprehensive upfront risk identification, detailed risk response planning, and formal change control, given the regulatory constraints and fixed validation requirements
Explanation
This scenario presents a heavily regulated pharmaceutical project with fixed compliance requirements, comprehensive validation protocols, baselined scope with formal sign-off, and explicit sponsor direction for formal change control. These characteristics strongly indicate a predictive approach is most appropriate. Risk management in this context requires comprehensive upfront identification of regulatory, validation, and compliance risks, detailed response planning that aligns with FDA requirements, and formal documentation for audit purposes. The regulatory deadline, fixed budget, and validation requirements create constraints that benefit from thorough advance planning rather than emergent discovery. While the operations director's desire for technician feedback is valid, the regulatory environment, formal change control requirement, already-baselined scope, and compliance documentation needs make a predictive risk management approach the best fit. The project manager should conduct structured risk workshops, maintain a formal risk register with response plans, and use established change control processes to manage any scope adjustments through proper validation impact assessment.
**Why not A:** A fully adaptive approach with iterative risk reviews every two weeks would not provide the comprehensive upfront risk identification this project requires. With fixed regulatory requirements, baselined scope, and formal change control mandated by the sponsor, waiting for risks to emerge iteratively creates unacceptable compliance risk.
**Why not B:** While a hybrid approach sounds reasonable, the scenario provides strong indicators that the entire project should follow a predictive risk management approach. The scope is already baselined with QA sign-off, the sponsor requires formal change control for any changes, and regulatory validation impacts demand comprehensive upfront planning rather than iterative discovery.
**Why not D:** Transitioning to a fully agile framework with risk assessment in sprint retrospectives contradicts every constraint in the scenario. Empowering the team to make real-time risk decisions without formal documentation would violate FDA 21 CFR Part 11 validation requirements and the sponsor's explicit directive for formal change control. This approach creates serious regulatory and compliance risks.
Key Concept
This question covers Monitor and adjust risk management activities under Assess and Manage Risks (Process).
This is 1 of 100 free PMP questions
Unlock 6,300+ PMP practice questions with detailed explanations, progress tracking, and exam readiness prediction.
Unlock All Questions